Document is current
Any future updates will be listed below
-
Authors
Hsu, Cynthia L.
Wang, Yanhan
Duan, Yi
Chu, Huikuan
Hartmann, Phillipp
Llorente, Cristina
Zhou, Rongrong
Schnabl, Bernd https://orcid.org/0000-0002-6281-825X
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (T32 DK007202)
Foundation for the National Institutes of Health (K12 HD85036)
Foundation for the National Institutes of Health (R01 AA24726)
Foundation for the National Institutes of Health (R37 AA020703)
Foundation for the National Institutes of Health (U01 AA026939)
Foundation for the National Institutes of Health (U01 AA026939-04S1)
Foundation for the National Institutes of Health (P30 DK120515)
Foundation for the National Institutes of Health (P50 AA011999)
National Institute of Environmental Health Sciences (KL2TR001444)
American Association for the Study of Liver Diseases (PNC22-159963)
U.S. Department of Veterans Affairs (BX004594)
Biocodex Microbiota Foundation
- License Information
-
More Information
Article History
Received: 16 August 2022
Accepted: 30 January 2023
First Online: 20 February 2023
Declarations
:
: B.S. has been consulting for Ambys Medicines, Ferring Research Institute, Gelesis, HOST Therabiomics, Intercept Pharmaceuticals, Mabwell Therapeutics, Patara Pharmaceuticals and Takeda. B.S.’s institution UC San Diego has received research support from Axial Biotherapeutics, BiomX, CymaBay Therapeutics, NGM Biopharmaceuticals, Prodigy Biotech and Synlogic Operating Company. B.S. is founder of Nterica Bio. UC San Diego has filed several patents with Y.D., C.L. and B.S. as inventors related to this work.
